This was significantly lower than that seen in HER2-negative breast cancer (16 : 1; P=0.046), HER2-positive EBC patients (30 : 1; P=0.017) and also HER2-positive MBC patients (40 : 1; P=0.014). Here, ERBB2 is linked to breast carcinoma.